Tradestie Institutional Equity Comparison Engine

CNSY vs MBRX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MBRX Overall Edge

MBRX Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Moleculin Biotech, Inc. (MBRX) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CNSY trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MBRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CNSY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MBRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MBRX
CNSY N/M vs MBRX N/M Fwd P/E
Growth & Margin Winner MBRX
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner MBRX
1Y -79.5% vs +1547.9% ยท 52W Pos 8% vs 73%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CNSY US Equity
CNSY
Institutional Equity
$0.72
-24.24% 1D
Market Cap N/A
1M Return -57.65%
1Y Return -79.55%
Forward P/E N/M
Unified AI Score
47.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 60.0
MBRX NASDAQ
Moleculin Biotech, Inc.
Pharmaceutical Preparations
$7.48
-4.96% 1D
Market Cap $7.9M
1M Return +2567.62%
1Y Return +1547.94%
Forward P/E N/M
Unified AI Score
35.5 / 100 SELL
Tech 24.0 Fund 33.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CNSY -79.55% MBRX +1547.94% Spread: +1739.55 pp (MBRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CNSY TTM Op. Margin: N/A MBRX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNSY vs MBRX. Trailing 12-month operating profitability (CNSY N/A vs MBRX 0.0%) and valuation multiples (CNSY N/M vs MBRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CNSY (2) vs MBRX (7)
Institutional Metric CNSY MBRX Criterion Row Winner
Market Capitalization Scale N/A $7.9M Larger Scale MBRX
Trailing P/E Ratio Valuation N/M 0.0x Lower Multiple MBRX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth MBRX
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin MBRX
Net Profit Margin Profitability N/A 0.0% Higher Margin MBRX
Return on Equity (ROE) Capital Efficiency N/A -1371.6% Higher ROE MBRX
52-Week Range Position Momentum 8% ($0โ€“$4) 73% ($0โ€“$10) Stronger Trend MBRX
Beta / 30D Volatility Risk Regime 2.54ฮฒ ยท 228% Vol 4.61ฮฒ ยท 7732% Vol Lower Realized Risk CNSY
Unified Institutional Score Composite Signal 47.6 / 100 (HOLD) 35.5 / 100 (SELL) Higher Composite CNSY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CNSY vs MBRX Buy Guide
CNSY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CNSY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MBRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MBRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CNSY nor MBRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.